Kamelia Faisal
Director/Board Member at PT ENVY TECHNOLOGIES INDONESIA TBK
Profile
Kamelia Faisal is currently the Director-Sales & Marketing at PT Indofarma Tbk and a Commissioner at PT Envy Technologies Indonesia Tbk.
In the past, she was the Director-Operational at PT Pertamedika Sentul City from 2013 to 2017, Director-Operation & Development at PT Pertamina Bina Medika from 2001 to 2019, and an Independent Commissioner at PT Kimia Farma Tbk from 2021 to 2022.
She has a graduate degree from the University of Indonesia and an undergraduate degree from Universitas Trisakti.
Kamelia Faisal active positions
Companies | Position | Start |
---|---|---|
PT INDOFARMA TBK | Sales & Marketing | 2022-05-30 |
PT ENVY TECHNOLOGIES INDONESIA TBK | Director/Board Member | - |
Former positions of Kamelia Faisal
Companies | Position | End |
---|---|---|
PT KIMIA FARMA TBK | Director/Board Member | 2022-10-13 |
PT Pertamina Bina Medika
PT Pertamina Bina Medika Medical/Nursing ServicesHealth Services PT Pertamina Bina Medika provides healthcare services and is ultimately controlled by the Government of Indonesia. The private company is based in Jakarta, Indonesia. | Chief Operating Officer | 2018-12-31 |
PT Pertamedika Sentul City | Chief Operating Officer | 2016-12-31 |
Training of Kamelia Faisal
University of Indonesia | Graduate Degree |
Universitas Trisakti | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PT KIMIA FARMA TBK | Health Technology |
PT INDOFARMA TBK | Health Technology |
PT ENVY TECHNOLOGIES INDONESIA TBK | Technology Services |
Private companies | 2 |
---|---|
PT Pertamedika Sentul City | |
PT Pertamina Bina Medika
PT Pertamina Bina Medika Medical/Nursing ServicesHealth Services PT Pertamina Bina Medika provides healthcare services and is ultimately controlled by the Government of Indonesia. The private company is based in Jakarta, Indonesia. | Health Services |
- Stock Market
- Insiders
- Kamelia Faisal